缺血和无阻塞性冠状动脉疾病 (INOCA):开发基于证据的治疗方法和未来十年的研究议程
C Noel Bairey Merz1, Carl J Pepine2, Mary Norine Walsh2
1From Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Division of Cardiology, University of Florida, Gainesville (C.J.P.); St. Vincent Heart Transplant, Indianapolis, IN (M.N.W.); and National Heart, Lung, and Blood Institute, Bethesda, MD (J.L.F.). merz@cshs.org.
Circulation
|March 15, 2017
概括
没有冠状动脉阻塞的心肌缺血患者面临更高的心血管事件风险. 这份共识报告概述了综合管理策略,并指出了这种疾病的研究缺口.
科学领域:
- 心脏病学
- 心血管研究
背景情况:
- 没有冠状动脉阻塞的心肌缺血 (INOCA) 影响了大量患者.
- 这些患者患有心血管不良事件的风险增加,包括急性冠状动脉综合征和心力衰竭.
- 一部分INOCA患者出现冠状动脉微血管功能障碍和炎症.
研究的目的:
- 在没有阻塞性冠状动脉的情况下形成心肌缺血综合征.
- 为识别和管理INOCA患者提供综合方法的建议.
- 概述知识缺口,并建议未来的研究方向.
主要方法:
- 召集了一个主要心血管组织的代表工作组.
- 批判性地审查了可用的文献和当前风险评估实践.
- 专注于最先进的科学技术和基于证据的治疗开发.
主要成果:
- 患有INOCA的患者患有心血管事件和心力衰竭的风险增加.
- 在INOCA患者的一小组中存在冠状动脉微血管功能障碍和炎症.
- 确定了未来研究的关键领域,以推进INOCA管理.
结论:
- 需要一个综合的方法来识别和管理INOCA.
- 为了开发基于证据的INOCA治疗方法,进一步的研究至关重要.
- 解决知识差距将改善INOCA患者的治疗结果.
相关概念视频
Ischemic Heart Disease: Overview
3.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Coronary Artery Disease V: Interprofessional Care
354
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Acute Coronary Syndrome IV: Interprofessional Care
358
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
590
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Angina IV: Management
368
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Coronary Artery Disease II: Pathophysiology
847
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847


